Bond Screener
Edwards Lifesciences
LEI YA13X31F3V31L8TMPR58, SWIFT ELFCUS66XXX
Organization name
Edwards Lifesciences Corporation
Country name
USA
Country of registration
USA
Industry
Medical Devices
Credit Ratings
in foreign currency
Public debt
600 mln USD
Upgrade to Premium features
Cbonds consolidates global bond, stock, ETF and indices data into a single platform — so you can analyze faster, make informed investment decisions and outperform the market
Get access
-
Full access to the largest bond database
Bond parameters,
prospectuses -
Seamless
Data exportAnalyze the data in the most efficient way
-
Bond pricing
Current & historical quotes from 400+ stock exchanges & OTC market
-
Smart risk assessment
Credit ratings, financial reports
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Edwards Lifesciences Corporation (Edwards Lifesciences) is focused on technologies that treat structural heart disease and critically ill patients. A pioneer in the development and commercialization of heart valve products, Edwards Lifesciences is the manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. The Company also provides hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The products and technologies provided by Edwards Lifesciences to treat advanced cardiovascular disease or critically ill patients are categorized into three main areas: Surgical Heart Valve Therapy, which combines surgical heart valves and Cardiac Surgery Systems; Transcatheter Heart Valves; and Critical Care, which includes Vascular. In October 2012, it acquired BMEYE B.V.
|
General information
-
Organization nameEdwards Lifesciences Corporation
-
Organization statusOperating organization
-
AddressC/O The Corporation Trust Company Corporation Trust Center 1209 Orange Street Wilmington, USA, 19801
-
Site
News
IFRS/US GAAP reports
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show all
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameEdwards Lifesciences Corporation
-
Organization statusOperating organization
-
AddressC/O The Corporation Trust Company Corporation Trust Center 1209 Orange Street Wilmington, USA, 19801
-
Site
Codes
-
LEIYA13X31F3V31L8TMPR58
-
SWIFTELFCUS66XXX
-
SIC3842 ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
-
CIK0001099800
-
EIN36-4316614
